Company
ChinaShenzhen Hepalink Pharmaceutical Co., Ltd., Shenzhen, China – FDA Inspections
Inspection records and compliance data for Shenzhen Hepalink Pharmaceutical Co., Ltd. in Shenzhen. 5 FDA inspections on record, last inspected January 13, 2020.
Company Profile
This profile covers Shenzhen Hepalink Pharmaceutical Co., Ltd. based in Shenzhen, China.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 2
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected November 26, 2008. Last inspected January 13, 2020.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 13, 2020 | VAI | Human Drugs · Drug Quality Assurance | 1134048 |
| June 16, 2016 | NAI | Human Drugs · Drug Quality Assurance | 988107 |
| January 15, 2013 | VAI | Human Drugs · Drug Quality Assurance | 823038 |
| January 27, 2011 | NAI | Human Drugs · Drug Quality Assurance | 717785 |
| November 26, 2008 | NAI | Human Drugs · Drug Quality Assurance | 556264 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- China NMPA · 1 inspection · last September 21, 2018
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Shenzhen Hepalink Pharmaceutical Co., Ltd.
FEI Number
3002808210
Address
Songpingshan, 21 Langshan Road; Nanshan District, Shenzhen, China
Country
China
ID: 73ab214e-7ba7-4484-bce3-4bf799bfa729